TRAMADOL-ACET 37.5 MG
TRAMADOL HYDROCHLORIDE : 37.5 MG ACETAMINOPHEN : 325 MG · DIN 02417502 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is TRAMADOL-ACET?
TRAMADOL-ACET 37.5 MG contains TRAMADOL HYDROCHLORIDE : 37.5 MG ACETAMINOPHEN : 325 MG. It is listed in the Health Canada Drug Product Database under DIN 02417502, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 11-Sep-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02417502 |
|---|---|
| Brand name | TRAMADOL-ACET |
| Generic / active ingredient | TRAMADOL HYDROCHLORIDE : 37.5 MG ACETAMINOPHEN : 325 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 37.5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ13 TRAMADOL AND PARACETAMOL |
| AHFS class | 28:08.92 ; 28:08.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 11-Sep-2019 |
| Original market date | 2014-02-03 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N02AJ13 TRAMADOL AND PARACETAMOL. 8 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-TRAMADOL/ACET | 325 MG | TABLET | APOTEX INC | MARKETED | DIN 02336790 |
| AURO-TRAMADOL/ACETAMINOPHEN | 37.5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02439050 |
| JAMP-ACET-TRAMADOL | 325 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02388308 |
| MAR-TRAMADOL/ACET | 37.5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02388324 |
| MINT-TRAMADOL/ACET | 325 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02389800 |
| PRZ-TRAMADOL/ACET | 325 MG | TABLET | PHARMARIS CANADA INC | MARKETED | DIN 02551047 |
| TARO-TRAMADOL/ACET | 37.5 MG | TABLET | SUN PHARMA CANADA INC | MARKETED | DIN 02388197 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 325 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02347180 |
| ACT TRAMADOL/ACET | 37.5 MG | TABLET | ACTAVIS PHARMA COMPANY | CANCELLED POST MARKET | DIN 02383209 |
| AG-ACET-TRAMADOL | 325 MG | TABLET | ANGITA PHARMA INC. | APPROVED | DIN 02477092 |
Who else supplies TRAMADOL AND PARACETAMOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRAMADOL AND PARACETAMOL appears in 695 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.